Similar articles

• Formation and repair of cisplatin-induced adducts to DNA in cultured normal and repair-deficient human fibroblasts.

  Dijt FJ, Fichtinger-Schepman AM, Berends F, Reedijk J. Dijt FJ, et al. Cancer Res. 1988 Nov 1;48(21):6058-62. Cancer Res. 1988. PMID: 3167856
• Formation and repair of DNA interstrand cross-links in relation to cytotoxicity and unscheduled DNA synthesis induced in control and mutant human cells treated with cis-diamminedichloroplatinum(II).

  Plooy AC, van Dijk M, Berends F, Lohman PH. Plooy AC, et al. Cancer Res. 1985 Sep;45(9):4178-84. Cancer Res. 1985. PMID: 3928152
• In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair.

  Fink D, Zheng H, Nebel S, Norris PS, Aebi S, Lin TP, Nehmé A, Christen RD, Haas M, MacLeod CL, Howell SB. Fink D, et al. Cancer Res. 1997 May 15;57(10):1841-5. Cancer Res. 1997. PMID: 9157971
• Insights into mechanisms of cisplatin resistance and potential for its clinical reversal.

  Gosland M, Lum B, Schimmelpfennig J, Baker J, Doukas M. Gosland M, et al. Pharmacotherapy. 1996 Jan-Feb;16(1):16-39. Pharmacotherapy. 1996. PMID: 8700790 Review.
• Cisplatin.

  Reed E. Reed E. Cancer Chemother Biol Response Modif. 1997;17:132-8. Cancer Chemother Biol Response Modif. 1997. PMID: 9551212 Review. No abstract available.